Research graph
References from Evaluating the Efficacy of Cytokine‐Directed Therapies in the Management of VEXAS Syndrome. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1056/nejmoa2026834
10.1056/nejmoa2026834 · External reference
10.1097/rhu.0000000000001905
10.1097/rhu.0000000000001905 · External reference
VEXAS syndrome
2021 · External reference
10.1016/j.mayocp.2021.06.006
10.1016/j.mayocp.2021.06.006 · External reference
10.1093/rheumatology/keab225
10.1093/rheumatology/keab225 · External reference
10.1002/ajh.27156
10.1002/ajh.27156 · External reference
10.1093/rheumatology/kead240
10.1093/rheumatology/kead240 · External reference
10.1002/ajh.70401
10.1002/ajh.70401 · External reference
10.1007/s00277-024-05942-2
10.1007/s00277-024-05942-2 · External reference
10.1182/blood.2020010177
10.1182/blood.2020010177 · External reference
10.1038/s41375-022-01698-8
10.1038/s41375-022-01698-8 · External reference
10.1002/art.43287
10.1002/art.43287 · External reference
10.1136/ard-2024-225640
10.1136/ard-2024-225640 · External reference
10.1016/s2665-9913(25)00034-7
10.1016/s2665-9913(25)00034-7 · External reference
10.3389/fphar.2025.1462254
10.3389/fphar.2025.1462254 · External reference
10.1016/j.ard.2025.05.021
10.1016/j.ard.2025.05.021 · External reference
Spectrum of clonal hematopoiesis in VEXAS syndrome
2023 · External reference
10.1111/bjd.20805
10.1111/bjd.20805 · External reference
10.1182/blood.2022016642
10.1182/blood.2022016642 · External reference
10.1016/s2665-9913(25)00074-8
10.1016/s2665-9913(25)00074-8 · External reference
10.1002/ajh.27169
10.1002/ajh.27169 · External reference
